Results 231 to 240 of about 2,308,170 (352)

Market potential of biobased chemicals: a qualitative network analysis of adoption dynamics in South Africa’s bioeconomy

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree, George Alex Thopil, Santosh Ramchuran   +2 more
wiley   +1 more source

Collective bargaining and social dialogue as instruments to protect workers from heatwaves and climate change in the European Union. [PDF]

Ind Health
Riesco-Sanz A.
europepmc   +1 more source

Increasing Use of 'Negotiated' Instruments of European Competition Law Enforcement Towards Foreign Companies

, 2014
Ewelina D. Sage
openalex   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Heat stress and social dialogue in the Netherlands: findings from the ADAPTHEAT-project. [PDF]

Ind Health
Popma J, Brinkhuis W.
europepmc   +1 more source

Neglected Alternatives for Investor Self-Help: The Unregistered Investment Company and the Federal Corporate Law

, 1969
Parker M. Nielson
openalex   +1 more source

Whose game is it anyway? Palworld and the new frontier of intellectual property in eSports. [PDF]

Front Sports Act Living
Vargas-Chaves I, Inoñán-Mujica Y, González-Herrera JM, Anacleto-Gómez JS.   +3 more
europepmc   +1 more source

Sustainable Companies: Spanish Mapping Paper on Company Law Issues

, 2012
Elena Escrig‐Olmedo, María Jesús Muñoz Torres, María Ángeles Fernández Izquierdo, Raúl León Soriano, Juana María Rivera‐Lirio, Idoya Ferrero‐Ferrero   +5 more
openalex   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers

British Journal of Clinical Pharmacology, EarlyView.
Aim Fluorescence‐guided surgery enhances intraoperative visualization of anatomical structures. Nizaracianine is a near‐infrared fluorescent agent that is exclusively renally cleared in animal models. It enables real‐time ureteral imaging and identification, potentially reduces risk of injury and facilitates assessment before surgical closure.
Lisanne K. A. Neijenhuis, Cedric M. W. Pesch, John V. Frangioni, Alexander L. Vahrmeijer, Jacobus Burggraaf, Naomi B. Klarenbeek   +5 more
wiley   +1 more source